Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Milestone Pharmaceuticals (MIST) IPO Opens 4% Higher
May 9, 2019 10:02 AM EDTToday's IPO for Milestone Pharmaceuticals Inc. (NASDAQ: MIST) opened for trading at $15.61 after pricing its upsized initial public offering of 5,500,000 of its common shares at a public offering price of $15.00 per share.
In addition, Milestone has granted certain of the underwriters a 30-day... More
